Use-results survey for E-fen buccal tablet

Trial Profile

Use-results survey for E-fen buccal tablet

Phase of Trial: Phase IV

Latest Information Update: 06 Feb 2018

At a glance

  • Drugs Fentanyl (Primary)
  • Indications Cancer pain
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Taiho Pharmaceutical Company
  • Most Recent Events

    • 05 Feb 2018 Status changed from active, no longer recruiting to completed.
    • 14 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top